Patient | Age | Tumor size (mm) | Pathology | Infiltration/Extension | Metastatic lymph nodes | Tg ** | Metastases * | Follow up (mo) | Recurrence/persistent disease |
---|---|---|---|---|---|---|---|---|---|
PA | 50 | 10 | P-f | 5 | 27.6 | Upper mediastinum Lymph nodes | 39 | CLN | |
TZ | 43 | 4 | P-f | Thyr capsule Thyr parenchyma | 2 | 43.7 | 51 | - | |
KΠ | 58 | 8 | P-f | - | 1 | 59.3 | 41 | - | |
GM | 40 | 10 & 2 & 2 | P-f | Thyr capsule Thyr parenchyma | 4 | 0.4 | 36 | - | |
MT | 57 | 10 & 2 & 1 | P-f | Thyr capsule Thyr parenchyma | 7 | 43.0 | 75 | CLN c | |
SE | 37 | 4 | P | - | 11 | 1.9 | 60 | - | |
KT | 34 | 10 & 2 | P | Thyr parenchyma Fatty tissue | 3 | 19.5 | 140 | CLN | |
KM | 26 | 2 & 5 | P | - | 1 | 0.8 | 56 | _ | |
AA | 56 | 5 | P | - | 1 | 25.7 | 34 | CLN | |
LC | 63 | 1 | P-f | - | 2 | 0.7 | 46 | - | |
HD | 33 | 8 | P-f | Thyr capsule Thyr parenchyma | 3 | 5.9 | 48 | - | |
HS | 56 | 10 & 3 & 2 | P-f | Thyr parenchyma Fatty tissue | 1 | 3.7 | 34 | - | |
MD | 38 | 7 | P-f | - | 1 | 7.7 | 44 | - | |
TP | 32 | 2 & 10 | P | - | 3 | 0.5 | 38 | - | |
SP | 37 | 8 & 10 | P | Nodule capsule Fatty tissue | 9 | 503.0 | Lower mediastinum Lymph nodes | 58 | _ |
GK | 24 | 7 & 8 | P-f | - | 2 | 2631.0 | Parapharyngeal area | 48 | _ |
HI | 28 | 9 | P-f | - | 1 | 5.3 | 36 | - | |
ZS | 57 | 10 | P | Nodule capsule | 2 | 8.7 | 40 | - | |
KA | 21 | 7 | P | - | 1 | 2.3 | 102 | - | |
NG | 16 | 9 | P-f | Thyr capsule Thyr parenchyma | 3 | 27.7 | Upper mediastinum lymph nodes | 56 | CLN |
PF | 26 | 8 & 9 | P-f | Thyr capsule Thyr parenchyma | 8 | 134.0 | Upper mediastinum lymph nodes | 42 | CLN |
VA | 58 | 8 & 5 | P | Thyr parenchyma Fatty tissue | 4 | 0.3 | 130 | - | |
AS | 42 | 8 | P-f | Thyr capsule Thyr parenchyma | 4 | 791.2 | 40 | CLN | |
BE | 27 | 5 | P-f | Thyr capsule Thyr parenchyma | 7 | 0.3 | 42 |